Miao X - Search Results

1

Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBM.

Li W, Miao X, Liu L, Zhang Y, Jin X, Luo X, Gao H, Deng X. Li W, et al. Among authors: miao x. Oncotarget. 2017 Apr 11;8(15):25167-25176. doi: 10.18632/oncotarget.15531. Oncotarget. 2017. PMID: 28445937 Free PMC article.

2

Down-regulation of microRNA-224 -inhibites growth and epithelial-to-mesenchymal transition phenotype -via modulating SUFU expression in bladder cancer cells.

Miao X, Gao H, Liu S, Chen M, Xu W, Ling X, Deng X, Rao C. Miao X, et al. Int J Biol Macromol. 2018 Jan;106:234-240. doi: 10.1016/j.ijbiomac.2017.07.184. Epub 2017 Aug 2. Int J Biol Macromol. 2018. PMID: 28780419

3

LncRNA ZEB2-AS1 promotes pancreatic cancer cell growth and invasion through regulating the miR-204/HMGB1 axis.

Gao H, Gong N, Ma Z, Miao X, Chen J, Cao Y, Zhang G. Gao H, et al. Among authors: miao x. Int J Biol Macromol. 2018 Sep;116:545-551. doi: 10.1016/j.ijbiomac.2018.05.044. Epub 2018 May 9. Int J Biol Macromol. 2018. PMID: 29753015

4

Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma.

Ma L, Zhang G, Miao XB, Deng XB, Wu Y, Liu Y, Jin ZR, Li XQ, Liu QZ, Sun DX, Testa JR, Yao KT, Xiao GH. Ma L, et al. FEBS J. 2013 May;280(9):2027-41. doi: 10.1111/febs.12226. Epub 2013 Apr 8. FEBS J. 2013. PMID: 23461856 Free PMC article.

5

Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer.

Li QQ, Xie YK, Wu Y, Li LL, Liu Y, Miao XB, Liu QZ, Yao KT, Xiao GH. Li QQ, et al. Oncotarget. 2017 Feb 14;8(7):12067-12080. doi: 10.18632/oncotarget.14512. Oncotarget. 2017. PMID: 28076844 Free PMC article.

6

A novel miR-200c/c-myc negative regulatory feedback loop is essential to the EMT process, CSC biology and drug sensitivity in nasopharyngeal cancer.

Yang J, Wu SP, Wang WJ, Jin ZR, Miao XB, Wu Y, Gou DM, Liu QZ, Yao KT. Yang J, et al. Exp Cell Res. 2020 Jun 15;391(2):111817. doi: 10.1016/j.yexcr.2020.111817. Epub 2020 Mar 13. Exp Cell Res. 2020. PMID: 32179097

7

MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9.

Rao C, Miao X, Zhao G, Zhang C, Shen H, Dong C, Yang M. Rao C, et al. Among authors: miao x. Biomed Pharmacother. 2019 Jun;114:108662. doi: 10.1016/j.biopha.2019.108662. Epub 2019 Apr 15. Biomed Pharmacother. 2019. PMID: 30999114 Free article.

8

Knockdown of lncRNA ZFAS1-suppressed non-small cell lung cancer progression via targeting the miR-150-5p/HMGA2 signaling.

Zeng Z, Zhao G, Rao C, Hua G, Yang M, Miao X, Ying J, Nie L. Zeng Z, et al. Among authors: miao x. J Cell Biochem. 2020 Aug;121(8-9):3814-3824. doi: 10.1002/jcb.29542. Epub 2019 Nov 6. J Cell Biochem. 2020. PMID: 31692094

9

Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity.

Zhang G, Ma L, Xie YK, Miao XB, Jin C. Zhang G, et al. Mol Med Rep. 2012 Sep;6(3):519-24. doi: 10.3892/mmr.2012.939. Epub 2012 Jun 8. Mol Med Rep. 2012. PMID: 22684859

10

Case report: Durable response to alectinib in ALK-rearranged lung adenocarcinoma with acquired, crizotinib-resistant ALK C1156F mutation.

Rao C, Nie L, Wu X, Miao X, Chen T, Chen L, Zhang D, Lin Q. Rao C, et al. Among authors: miao x. Front Oncol. 2022 Sep 20;12:915502. doi: 10.3389/fonc.2022.915502. eCollection 2022. Front Oncol. 2022. PMID: 36203454 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,887 results

Search Page

Filters